Bluemtec Names KDBI Healthcare Value-Up as New Buyer of 21.07% Stake in Corrected Filing
Bitget2026/10/30 10:40- Bluemtec’s October 30, 2026, correction names KDBI Healthcare Value-Up as buyer in place of KDB Investment following assignment of contractual rights.
- The new buyer will acquire 7,131,777 shares, representing a 21.07% stake, to become the largest shareholder.
- Transaction terms remain unchanged at KRW 23.07 billion, or KRW 3,235 per share.
- Closing is scheduled for November 27, 2026, subject to conditions, with full payment due at completion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Indonesian Rupiah: External headwinds and MSCI risks – OCBC
Taiwan Dollar: Strong fundamentals but near-term pressure – Commerzbank

Hassett Downplays AI Debt Risk: The Industry Has Sufficient Funds, No Risk of Broad Sell-Off
Kevin Hassett, Director of the White House National Economic Council, stated that the recent substantial decline in technology stocks does not indicate a comprehensive sell-off risk for the AI industry. He acknowledged that some enterprises are indeed burdened with significant debt, which warrants attention. However, he also pointed out that there are many financially strong companies within the industry that hold both equity and debt in related firms; these companies may be poised to acquire or provide funding support when opportunities arise.
